Drugs / Lysozyme
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT05519254 | Mar 2023 → Jul 2026 overdue | diarrheal disease, protein-energy malnutrition | University of Washington | Recruiting | No outcome recorded |
| Phase 3 | NCT03282045 | Oct 2016 → May 2018 | pharyngitis | Bosnalijek D.D | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT01715493 | Oct 2012 → Dec 2013 | asthma, chronic obstructive pulmonary disease | Eisai Inc. | Completed | No outcome recorded |
| Phase 4 | NCT01645800 | Aug 2012 → Jan 2015 | chronic obstructive pulmonary disease | Eisai Inc. | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT06106880 Comparator | May 2022 → Apr 2023 | Achoo syndrome, common cold, headache disorder, pharyngitis +1 | Applied Biological Laboratories Inc | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT05342272 Comparator | Sep 2017 → Jan 2018 | — | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lysozyme | “one press of the spray pump release 0.20 mL of the solution containing 4 mg lysozyme, 0.3 mg cetylpyridine and 0.1 mg lidocaine hydrochloride.” NCT03282045 ↗5“The liquid spray contained wintergreen oil, menthol, lactoferrin, lysozyme, aloe, and glycerin.” NCT06106880 ↗ |
| Route | Other | “The liquid spray contained wintergreen oil, menthol, lactoferrin, lysozyme, aloe, and glycerin.” NCT06106880 ↗ |